Delivery Order SPE2DB20D3303-SPE2DB25FY2F1
Award Date
10/25/24
Potential Completion Date
10/28/24
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $38,542.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 32 mg tablets, which are used to treat high blood pressure and heart failure. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $31,085.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Candesartan Cilexetil 32 mg tablets, a medication used to treat high blood pressure and heart failure. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $2,126.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. The contract is for the delivery of Candesartan Cilexetil 32 mg tablets, a medication used to treat...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $66,624.96 firm-fixed-price delivery order covers the supply of Candesartan Cilexetil 32 mg tablets, a medication used to treat high blood pressure and heart failure. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $5,534.12 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 8 mg tablets, a medication used to treat high blood pressure and heart failure. The award falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,022.52 firm fixed-price contract is for the delivery of candesartan cilexetil 32 mg tablets, which are used to treat high blood pressure and heart failure. The contract has an ultimate completion date of August 12, 2022. The delivery order was issued under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $7,464.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Candesartan Cilexetil 16 mg tablets, a medication used to treat high blood pressure and heart failure. The contract is a Firm Fixed Price Delivery Order with a period of performance ending on January 9, 2025. It is not designated as a set-aside contract....
This federal contract award, valued at $7,632.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Candesartan Cilexetil 16 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. It is a firm fixed-price contract, with no set-aside designation....
This federal contract award, valued at $7,607.77, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Candesartan Cilexetil 32 mg tablets, a cardiovascular medication, with an ultimate completion date of November 26, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award, valued at $4,504.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 32 mg tablets, a cardiovascular medication, with an ultimate completion date of December 4, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...